Patent · US Expired

Gepirone dosage form

US5478572A · kind A · utility

4Cited by

28References

16Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Stephen T. David · Evansville, US
Claude E. Gallian · Newburgh, US
Joseph Chou · Coral Springs, US

Key dates

Filing date	Sep 6, 1994
Grant date	Dec 26, 1995
Priority date	—
Expiry date	Sep 6, 2014

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Gepirone compositions having extended release properties contain a gepirone salt, a cellulosic polymer matrix and suitable quantities of pharmaceutical excipients. Dosage forms based thereon require 18 to 24 hours for release of 90 to 95% of gepirone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.